153: Why Amylin May Be the Most Important Weight Loss Hormone You've Never Heard Of
📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-dig... 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Topic: Amylin is an insulin-sparing satiety hormone released with insulin that slows digestion, restrains glucagon, and helps reduce post-meal glucose spikes. New amylin-based therapies, especially when combined with GLP-1 drugs, may offer powerful weight-loss effects by restoring natural fullness signals rather than forcing insulin higher. Summary: In this lecture, Dr. Bikman explains amylin, a hormone released from the pancreatic beta cell alongside insulin. While insulin helps move nutrients into tissues, amylin works mainly through the brain and digestive tract to increase fullness, slow gastric emptying, restrain post-meal glucagon, and reduce blood sugar spikes without forcing insulin higher. This makes amylin an insulin-sparing hormone and a natural complement to GLP-1. Ben explains why amylin was difficult to turn into a drug: human amylin naturally tends to misfold and form amyloid deposits in the pancreas. Protein engineering solved this problem by creating analogs that activate the amylin receptor without clumping. The first amylin-based drug, pramlintide, proved the concept by reducing appetite, slowing digestion, blunting post-meal glucose rises, and producing modest weight loss, though its short duration and nausea limited broader use. The lecture then moves into newer amylin-based therapies, especially cagrilintide and the combination drug CagriSema, which pairs cagrilintide with semaglutide. Because amylin and GLP-1 work through overlapping but distinct brain pathways, the combination produces greater weight loss than either hormone strategy alone. The takeaway is that amylin may become one of the most important next-generation targets in metabolic medicine because it supports satiety and glucose control without driving insulin higher. References: For complete show notes and references, we invite you to become an Insider subscriber. You’ll enjoy real-time, livestream Metabolic Classroom access which includes live Q&A with Ben after the lecture, unlimited access to Dr. Bikman’s Digital Mind, ad-free podcast episodes, show notes and references, and Ben’s Weekly Research Review Podcast. Learn more: https://www.benbikman.com Translation Notes: You can click the gear icon at the bottom of this video to auto-translate captions. For example, to translate into Polish, select Subtitles, choose Auto-Translate, then first choose English, then choose Auto-Translate again, then choose Polish.) Also, Dr. Bikman’s Digital Mind can interact with you in many languages: https://benbikman.com/ben-bikmans-dig... In addition, our channel has access to YouTube’s innovative “auto-dubbing” feature. The process supports translations from English into many languages, with more to come. Click on the gear icon, then choose “Audio track” to access. (This availability is often delayed several weeks or more, so check back often.) Timestamps (approximate): 00:44 — Intro Hook: Amylin and the Future of Weight Loss 01:46 — What Amylin Is 02:41 — Insulin and Amylin Are Released Together 03:52 — Amylin’s Effects on Satiety, Digestion, and Glucagon 04:57 — Why Amylin Is Insulin-Sparing 06:04 — Why Human Amylin Was Hard to Turn Into a Drug 10:17 — Why Pramlintide Was Limited 11:22 — Why Amylin and GLP-1 Work Well Together 12:19 — Amylin, Leptin Sensitivity, and Satiety 13:42 — Why the Combination Is Metabolically Attractive 14:48 — Cagrilintide and CagriSema 19:15 — The Next Wave of Amylin-Based Drugs 20:22 — Final Takeaways: Amylin as GLP-1’s Complement NOTE: The information presented is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Dr. Bikman is not a clinician—and, he is not your doctor. Always seek the advice of your own qualified health providers with questions you may have regarding medical conditions. #Amylin #GLP1 #CagriSema #Cagrilintide #Pramlintide #MetabolicHealth #WeightLossScience #SatietyHormones #InsulinSparing #InsulinResistance #LeptinResistance #AppetiteControl #GastricEmptying #Glucagon #BloodSugarControl #DrBenBikman #MetabolicClassroom #MetabolismMatters #HealthScience #IncretinTherapy Ben’s favorite yerba mate and fiber: https://ufeelgreat.com/usa/en/c/1BA884 Exogenous ketones: A high-quality option is the NSF-certified goBHB from Clean Form Nutrition, where you can use the code BEN10 for a 10% discount: https://cleanformnutrition.com/produc... CKMs: SiBio CKM is offering a 5% discount using the code BEN5 at checkout. However, their CKM is not yet available in the US and Canada. You can submit your email on their website and they will notify you when it becomes available in your region: https://www.sibiosensor.com/BEN5 Ben’s favorite meal-replacement shake: https://gethlth.com (discount: BEN10)

151: Why Retatrutide May Outperform GLP-1 Drugs

2 Days of Sardines Revealed What Her Labs Missed

145: Why GLP-1 Drugs Don’t Fix High Insulin

Scientists Can Now Track Which Habits Age You Faster | Dr. Steve Horvath

This New Protein Study just Changed how we Think about Protein!

Insulin Scientist Reveals the Best Sweetener for Reducing Belly Fat - Dr. Bikman

136: Why Exercise Benefits Every Organ — Not Just Muscle — with Dr. Ben Bikman

Doctor Explains The Side Effects of Retatrutide (Heart Issues, Cancer & More)

144: Why Creatine Is One of the Most Important Brain Nutrients

150: Why Tirzepatide Works Better Than GLP-1 Alone

Trump Gets Booed & Falls Asleep During NBA Finals, Claims War is Almost Over & Goodbye Spencer Pratt

New Data on Retatrutide is out and it Needs to Be Talked About

131: GLP-1 Isn’t Enough - Why Glucagon is the Key to Lasting Weight Loss with Dr. Ben Bikman

How Did Ancient Women Handle Their Periods?

138: How Bile Controls Insulin, GLP-1, and Fat Burning with Dr. Ben Bikman

The SIMPLE Way To Clean Your FATTY Liver (Science Backed)

148: Why Neuropathy Isn’t Just About Blood Sugar

Hormone treatments after 70: why you don’t need to stop

Why I Take Low-Dose Tirzepatide (& Not Retatrutide)

